6-Fluoro-5-methylpyridine-3-carboxylic acid → [4-(3,5-Dimethylpyridin-2-yl)piperazin-1-yl](6-fluoro-5-methylpyridin-3-yl)methanone
Reaction equation
[F:1][C:2]1[C:10]([CH3:11])=[CH:9][C:5]([C:6]([OH:8])=O)=[CH:4][N:3]=1.[CH3:12][C:13]1[C:14]([N:20]2[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]2)=[N:15][CH:16]=[C:17]([CH3:19])[CH:18]=1>>[CH3:12][C:13]1[C:14]([N:20]2[CH2:21][CH2:22][N:23]([C:6]([C:5]3[CH:4]=[N:3][C:2]([F:1])=[C:10]([CH3:11])[CH:9]=3)=[O:8])[CH2:24][CH2:25]2)=[N:15][CH:16]=[C:17]([CH3:19])[CH:18]=1Participants
3
Procedure
By reaction and treatment in the same manner as in Preparation Example 60 and using 6-fluoro-5-methylnicotinic acid (500 mg) and 1-(3,5-dimethylpyridin-2-yl)piperazine (620 mg) described in Preparation Example 47, the title compound (1.1 g) was obtained.
Workup
- customBy reaction and treatment in the same manner
- customas in Preparation Example 60
- customdescribed in Preparation Example 47
Sources & evidence
- ORD record
- ord-4470b9ab8f704a2ab03654eaedf92f33
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…